The FDA has approved its use for chronic weight management in adults with a body mass index (BMI) of 30 or more, or a BMI of 27 or more when accompanied by at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes
Answer: It lightens the skin, evens out skin tone, removes spots and imperfections, and provides a radiant complexion
BNIP3L/NIX-mediated mitophagy protects against glucocorticoid-induced synapse defects
The most common user-reported experience: Temporary skin dryness in week 1 (resolves by week 2) Occasional injection site redness (standard for any subQ peptide) Some users report increased hair growth, including in unintended areas at higher doses At doses above 34 mg/day, some protocols note headaches, but this is well above standard dosing
Supplemental glutathione, especially via injection, may offer an efficient way to increase circulating levels